Korea Novel Drug Prices 50% Of Similar Countries, But A Window Opens For Reform
This article was originally published in PharmAsia News
Executive Summary
MNC pharma association in Korea lobbies for delinking generic drugs from new drug pricing in year ahead.
You may also be interested in...
Korean Health Ministry's New Pricing System Draws Industry Criticism
SEOUL - South Korea's Ministry of Health and Welfare held a two-day forum offering a rare opportunity for Korean and foreign pharmaceutical officials to offer comments on the ministry's controversial new pricing system
Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines
SEOUL - South Korea's antitrust watchdog the Fair Trade Commission said rebates by both multinational and local Korean pharmaceutical companies are continuing even though doctors can be punished for accepting rebates under a new law that took effect late last year
Early-Stage Idiopathic Pulmonary Fibrosis (IPF) Candidates Race to Phase III
Multiple IPF drugs are being rushed into Phase III based on early-stage signals of efficacy and safety presented at the ATS meeting. Scrip spoke with the University of Pittsburgh's Kevin Gibson about the candidates, trial design, combination therapy and limitations of current therapy.